Stocks and Investing Stocks and Investing
Fri, April 4, 2014
Thu, April 3, 2014
Wed, April 2, 2014
Tue, April 1, 2014
Mon, March 31, 2014
Fri, March 28, 2014

Liav Abraham Maintained (TEVA) at Strong Buy with Increased Target to $60 on, Mar 28th, 2014


Published on 2024-10-25 04:31:05 - WOPRAI, Liav Abraham
  Print publication without navigation


Liav Abraham of Citigroup, Maintained "Teva Pharmaceutical Industries Limited" (TEVA) at Strong Buy with Increased Target from $56 to $60 on, Mar 28th, 2014.

Liav has made no other calls on TEVA in the last 4 months.



There are 4 other peers that have a rating on TEVA. Out of the 4 peers that are also analyzing TEVA, 3 agree with Liav's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Chris Schott of "JP Morgan" Upgraded from Sell to Hold and Held Target at $49 on, Friday, March 14th, 2014
  • David Risinger of "Morgan Stanley" Upgraded from Sell to Hold and Held Target at $52 on, Friday, March 14th, 2014
  • Randall Stanicky of "RBC Capital" Initiated at Hold and Held Target at $39 on, Monday, January 6th, 2014


This is the rating of the analyst that currently disagrees with Liav


  • Ami Fadia of "Leerink Swann" Upgraded from Hold to Buy on, Thursday, March 6th, 2014
Contributing Sources